{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:24:09Z","timestamp":1788621849325,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"name":"University of Kentucky Alliance Research Initiative","award":["TILT Alliance"],"award-info":[{"award-number":["TILT Alliance"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001998"],"award-info":[{"award-number":["UL1TR001998"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH Cancer Center Support Grant","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}]},{"name":"NIH Cancer Center Support Grant","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}]},{"name":"NIH Cancer Center Support Grant","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}]},{"name":"NIH Cancer Center Support Grant","award":["P30CA177558"],"award-info":[{"award-number":["P30CA177558"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Regulatory T cells (Tregs) are essential to maintain self-tolerance and immune homeostasis but, as components of the tumor microenvironment (TME), are also a major barrier to effective cancer immunosurveillance and immunotherapy. FH535 and its derivative Y3 are two <jats:italic>N<\/jats:italic>-aryl-benzene-sulfonamides (NABs) that inhibit HCC cell proliferation and tumor progression. However, the impact of NABs on the immune cells in the TME is not yet known. Analyses of explanted livers from patients with hepatocellular carcinoma (HCC) showed that high levels of tumor-infiltrating Tregs were associated with poor tumor differentiation. These results lead us to investigate the immunomodulatory effects of NABs in regulatory and effector T cells. Exposure of primary human Tregs to NABs induced a rapid but temporary increase of cell expansion, a gradual disruption of suppressor activity, and concomitant bioenergetics and autophagic flux dysregulations. In contrast to Tregs, no gross effects were observed in effector T cells. Addition of Rapamycin prevented the functional decay of Tregs and restored their metabolic profile, suggesting that NAB effects require the integrity of the mTOR pathway. This study revealed the immunomodulatory properties of NABs with a preferential impact on Treg activity and provided novel insights into the anti-tumor potential of sulfonamides.<\/jats:p>","DOI":"10.1038\/s41598-022-23601-2","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:11:34Z","timestamp":1668021094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells"],"prefix":"10.1038","volume":"12","author":[{"given":"Roberto","family":"Gedaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilius","family":"Cornea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Turcios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Edmisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Chapelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonzalez-Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ruffing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asir","family":"Chishti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zwischenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"23601_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s10147-010-0131-0","volume":"15","author":"K Shirabe","year":"2010","unstructured":"Shirabe, K. et al. Tumor-infiltrating lymphocytes and hepatocellular carcinoma: Pathology and clinical management. Int. J. Clin. Oncol. 15, 552\u2013558. https:\/\/doi.org\/10.1007\/s10147-010-0131-0 (2010).","journal-title":"Int. J. Clin. Oncol."},{"key":"23601_CR2","doi-asserted-by":"publisher","first-page":"12802","DOI":"10.3390\/cancers12123802","volume":"12","author":"RC Augustin","year":"2020","unstructured":"Augustin, R. C., Delgoffe, G. M. & Najjar, Y. G. Characteristics of the tumor microenvironment that influence immune cell functions: Hypoxia, oxidative stress, metabolic alterations. Cancers (Basel) 12, 12802. https:\/\/doi.org\/10.3390\/cancers12123802 (2020).","journal-title":"Cancers (Basel)"},{"key":"23601_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1245\/s10434-012-2668-9","volume":"20","author":"SC Katz","year":"2013","unstructured":"Katz, S. C. et al. Regulatory t cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann. Surg. Oncol. 20, 946\u2013955. https:\/\/doi.org\/10.1245\/s10434-012-2668-9 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"23601_CR4","doi-asserted-by":"publisher","first-page":"030627","DOI":"10.3390\/cancers12030627","volume":"12","author":"N Chaoul","year":"2020","unstructured":"Chaoul, N., Mancarella, S., Lupo, L., Giannelli, G. & Dituri, F. Impaired anti-tumor t cell response in hepatocellular carcinoma. Cancers (Basel) 12, 030627. https:\/\/doi.org\/10.3390\/cancers12030627 (2020).","journal-title":"Cancers (Basel)"},{"key":"23601_CR5","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","volume":"4","author":"C Fitzmaurice","year":"2018","unstructured":"Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the global burden of disease study. JAMA Oncol. 4, 1553\u20131568. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2706 (2018).","journal-title":"JAMA Oncol."},{"key":"23601_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/jrms.JRMS_1017_18","volume":"24","author":"A Sarveazad","year":"2019","unstructured":"Sarveazad, A., Agah, S., Babahajian, A., Amini, N. & Bahardoust, M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J. Res. Med. Sci. 24, 86. https:\/\/doi.org\/10.4103\/jrms.JRMS_1017_18 (2019).","journal-title":"J. Res. Med. Sci."},{"key":"23601_CR7","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1038\/s41598-017-08128-1","volume":"7","author":"W Yao","year":"2017","unstructured":"Yao, W. et al. The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A systematic review and meta-analysis. Sci. Rep. 7, 7525. https:\/\/doi.org\/10.1038\/s41598-017-08128-1 (2017).","journal-title":"Sci. Rep."},{"key":"23601_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231003","volume":"15","author":"S Yu","year":"2020","unstructured":"Yu, S. et al. Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival. PLoS ONE 15, e0231003. https:\/\/doi.org\/10.1371\/journal.pone.0231003 (2020).","journal-title":"PLoS ONE"},{"key":"23601_CR9","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1016\/j.bmcl.2015.07.040","volume":"25","author":"LM Kril","year":"2015","unstructured":"Kril, L. M. et al. N-Aryl benzenesulfonamide inhibitors of [3h]-thymidine incorporation and beta-catenin signaling in human hepatocyte-derived huh-7 carcinoma cells. Bioorg. Med. Chem. Lett. 25, 3897\u20133899. https:\/\/doi.org\/10.1016\/j.bmcl.2015.07.040 (2015).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"23601_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.dld.2017.01.146","volume":"49","author":"L Turcios","year":"2017","unstructured":"Turcios, L. et al. Sorafenib and fh535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function. Dig. Liver Dis. 49, 697\u2013704. https:\/\/doi.org\/10.1016\/j.dld.2017.01.146 (2017).","journal-title":"Dig. Liver Dis."},{"key":"23601_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212538","volume":"14","author":"L Turcios","year":"2019","unstructured":"Turcios, L. et al. Autophagic flux modulation by wnt\/beta-catenin pathway inhibition in hepatocellular carcinoma. PLoS ONE 14, e0212538. https:\/\/doi.org\/10.1371\/journal.pone.0212538 (2019).","journal-title":"PLoS ONE"},{"key":"23601_CR12","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2005.00289.x","volume":"100","author":"C Zavaglia","year":"2005","unstructured":"Zavaglia, C. et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am. J. Gastroenterol. 100, 2708\u20132716. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.00289.x (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"23601_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archsurg.136.1.25","volume":"136","author":"S Tamura","year":"2001","unstructured":"Tamura, S. et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch. Surg. 136, 25\u201330 (2001).","journal-title":"Arch. Surg."},{"key":"23601_CR14","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.18632\/oncotarget.27680","volume":"11","author":"L Turcios","year":"2020","unstructured":"Turcios, L. et al. Mitochondrial uncoupling and the disruption of the metabolic network in hepatocellular carcinoma. Oncotarget 11, 3013\u20133024. https:\/\/doi.org\/10.18632\/oncotarget.27680 (2020).","journal-title":"Oncotarget"},{"key":"23601_CR15","doi-asserted-by":"publisher","first-page":"11348","DOI":"10.1021\/acs.jmedchem.9b01685","volume":"62","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. An underlying mechanism of dual wnt inhibition and ampk activation: Mitochondrial uncouplers masquerading as wnt inhibitors. J. Med. Chem. 62, 11348\u201311358. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01685 (2019).","journal-title":"J. Med. Chem."},{"key":"23601_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fimmu.2019.00111","volume":"10","author":"G Pawelec","year":"2019","unstructured":"Pawelec, G. Is there a positive side to t cell exhaustion? Front. Immunol. 10, 111. https:\/\/doi.org\/10.3389\/fimmu.2019.00111 (2019).","journal-title":"Front. Immunol."},{"key":"23601_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.2AB0514-273RR","volume":"97","author":"S Basu","year":"2015","unstructured":"Basu, S., Hubbard, B. & Shevach, E. M. Foxp3-mediated inhibition of akt inhibits glut1 (glucose transporter 1) expression in human t regulatory cells. J. Leukoc. Biol. 97, 279\u2013283. https:\/\/doi.org\/10.1189\/jlb.2AB0514-273RR (2015).","journal-title":"J. Leukoc. Biol."},{"key":"23601_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Cd36-mediated metabolic adaptation supports regulatory t cell survival and function in tumors. Nat. Immunol. 21, 298\u2013308. https:\/\/doi.org\/10.1038\/s41590-019-0589-5 (2020).","journal-title":"Nat. Immunol."},{"key":"23601_CR19","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1091\/mbc.e06-07-0593","volume":"18","author":"HL Wieman","year":"2007","unstructured":"Wieman, H. L., Wofford, J. A. & Rathmell, J. C. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase\/akt regulation of glut1 activity and trafficking. Mol. Biol. Cell 18, 1437\u20131446. https:\/\/doi.org\/10.1091\/mbc.e06-07-0593 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"23601_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00001","volume":"6","author":"CS Palmer","year":"2015","unstructured":"Palmer, C. S., Ostrowski, M., Balderson, B., Christian, N. & Crowe, S. M. Glucose metabolism regulates t cell activation, differentiation, and functions. Front. Immunol. 6, 1. https:\/\/doi.org\/10.3389\/fimmu.2015.00001 (2015).","journal-title":"Front. Immunol."},{"key":"23601_CR21","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3389\/fimmu.2019.02839","volume":"10","author":"RWM Kempkes","year":"2019","unstructured":"Kempkes, R. W. M., Joosten, I., Koenen, H. & He, X. Metabolic pathways involved in regulatory t cell functionality. Front. Immunol. 10, 2839. https:\/\/doi.org\/10.3389\/fimmu.2019.02839 (2019).","journal-title":"Front. Immunol."},{"key":"23601_CR22","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.18632\/oncotarget.6927","volume":"7","author":"N Safinia","year":"2016","unstructured":"Safinia, N. et al. Successful expansion of functional and stable regulatory t cells for immunotherapy in liver transplantation. Oncotarget 7, 7563\u20137577. https:\/\/doi.org\/10.18632\/oncotarget.6927 (2016).","journal-title":"Oncotarget"},{"key":"23601_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/TP.0000000000002495","volume":"103","author":"R Gedaly","year":"2019","unstructured":"Gedaly, R. et al. Mtor inhibitor everolimus in regulatory t cell expansion for clinical application in transplantation. Transplantation 103, 705\u2013715. https:\/\/doi.org\/10.1097\/TP.0000000000002495 (2019).","journal-title":"Transplantation"},{"key":"23601_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1600-6143.2011.03771.x","volume":"12","author":"M Tanemura","year":"2012","unstructured":"Tanemura, M. et al. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo. Am. J. Transplant. 12, 102\u2013114. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03771.x (2012).","journal-title":"Am. J. Transplant."},{"key":"23601_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.freeradbiomed.2021.04.025","volume":"169","author":"M Perluigi","year":"2021","unstructured":"Perluigi, M., Di Domenico, F., Barone, E. & Butterfield, D. A. Mtor in alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder. Free Radic. Biol. Med. 169, 382\u2013396. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.04.025 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"23601_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.exger.2016.08.002","volume":"83","author":"V Martinez-Cisuelo","year":"2016","unstructured":"Martinez-Cisuelo, V. et al. Rapamycin reverses age-related increases in mitochondrial ros production at complex i, oxidative stress, accumulation of mtdna fragments inside nuclear DNA, and lipofuscin level, and increases autophagy, in the liver of middle-aged mice. Exp. Gerontol. 83, 130\u2013138. https:\/\/doi.org\/10.1016\/j.exger.2016.08.002 (2016).","journal-title":"Exp. Gerontol."},{"key":"23601_CR27","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41423-021-00639-2","volume":"18","author":"O Ahmed","year":"2021","unstructured":"Ahmed, O., Robinson, M. W. & O\u2019Farrelly, C. Inflammatory processes in the liver: Divergent roles in homeostasis and pathology. Cell Mol. Immunol. 18, 1375\u20131386. https:\/\/doi.org\/10.1038\/s41423-021-00639-2 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"23601_CR28","first-page":"81","volume":"7","author":"G Deng","year":"2018","unstructured":"Deng, G. Tumor-infiltrating regulatory t cells: Origins and features. Am. J. Clin. Exp. Immunol. 7, 81\u201387 (2018).","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"23601_CR29","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1002\/eji.201343571","volume":"43","author":"GI Ellis","year":"2013","unstructured":"Ellis, G. I., Zhi, L., Akundi, R., Bueler, H. & Marti, F. Mitochondrial and cytosolic roles of pink1 shape induced regulatory t-cell development and function. Eur. J. Immunol. 43, 3355\u20133360. https:\/\/doi.org\/10.1002\/eji.201343571 (2013).","journal-title":"Eur. J. Immunol."},{"key":"23601_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. Mtorc1 couples immune signals and metabolic programming to establish t(reg)-cell function. Nature 499, 485\u2013490. https:\/\/doi.org\/10.1038\/nature12297 (2013).","journal-title":"Nature"},{"key":"23601_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ni.3365","volume":"17","author":"J Wei","year":"2016","unstructured":"Wei, J. et al. Autophagy enforces functional integrity of regulatory t cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17, 277\u2013285. https:\/\/doi.org\/10.1038\/ni.3365 (2016).","journal-title":"Nat. Immunol."},{"key":"23601_CR32","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: Distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory cd4+ t cell subsets. J. Immunol. 186, 3299\u20133303. https:\/\/doi.org\/10.4049\/jimmunol.1003613 (2011).","journal-title":"J. Immunol."},{"key":"23601_CR33","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ni.3269","volume":"16","author":"V De Rosa","year":"2015","unstructured":"De Rosa, V. et al. Glycolysis controls the induction of human regulatory t cells by modulating the expression of foxp3 exon 2 splicing variants. Nat. Immunol. 16, 1174\u20131184. https:\/\/doi.org\/10.1038\/ni.3269 (2015).","journal-title":"Nat. Immunol."},{"key":"23601_CR34","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.4049\/jimmunol.1600242","volume":"197","author":"M Galgani","year":"2016","unstructured":"Galgani, M., De Rosa, V., La Cava, A. & Matarese, G. Role of metabolism in the immunobiology of regulatory t cells. J. Immunol. 197, 2567\u20132575. https:\/\/doi.org\/10.4049\/jimmunol.1600242 (2016).","journal-title":"J. Immunol."},{"key":"23601_CR35","doi-asserted-by":"publisher","first-page":"e0121710","DOI":"10.1371\/journal.pone.0121710","volume":"10","author":"KN Pollizzi","year":"2015","unstructured":"Pollizzi, K. N., Waickman, A. T., Patel, C. H., Sun, I. H. & Powell, J. D. Cellular size as a means of tracking mtor activity and cell fate of cd4+ t cells upon antigen recognition. PLoS ONE 10, e0121710. https:\/\/doi.org\/10.1371\/journal.pone.0121710 (2015).","journal-title":"PLoS ONE"},{"key":"23601_CR36","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.4049\/jimmunol.1502464","volume":"197","author":"PJ Siska","year":"2016","unstructured":"Siska, P. J. et al. Suppression of glut1 and glucose metabolism by decreased akt\/mtorc1 signaling drives t cell impairment in b cell leukemia. J. Immunol. 197, 2532\u20132540. https:\/\/doi.org\/10.4049\/jimmunol.1502464 (2016).","journal-title":"J. Immunol."},{"key":"23601_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/imr.12845","volume":"295","author":"H Huang","year":"2020","unstructured":"Huang, H., Long, L., Zhou, P., Chapman, N. M. & Chi, H. Mtor signaling at the crossroads of environmental signals and t-cell fate decisions. Immunol. Rev. 295, 15\u201338. https:\/\/doi.org\/10.1111\/imr.12845 (2020).","journal-title":"Immunol. Rev."},{"key":"23601_CR38","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3466","volume":"17","author":"R Newton","year":"2016","unstructured":"Newton, R., Priyadharshini, B. & Turka, L. A. Immunometabolism of regulatory t cells. Nat. Immunol. 17, 618\u2013625. https:\/\/doi.org\/10.1038\/ni.3466 (2016).","journal-title":"Nat. Immunol."},{"key":"23601_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/ni.3077","volume":"16","author":"A Huynh","year":"2015","unstructured":"Huynh, A. et al. Control of pi(3) kinase in treg cells maintains homeostasis and lineage stability. Nat. Immunol. 16, 188\u2013196. https:\/\/doi.org\/10.1038\/ni.3077 (2015).","journal-title":"Nat. Immunol."},{"key":"23601_CR40","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets, V. A. et al. Foxp3 and toll-like receptor signaling balance treg cell anabolic metabolism for suppression. Nat. Immunol. 17, 1459\u20131466. https:\/\/doi.org\/10.1038\/ni.3577 (2016).","journal-title":"Nat. Immunol."},{"key":"23601_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.celrep.2019.03.029","volume":"27","author":"J Miska","year":"2019","unstructured":"Miska, J. et al. Hif-1alpha is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of tregs in glioblastoma. Cell Rep. 27, 226\u2013237. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.029 (2019).","journal-title":"Cell Rep."},{"key":"23601_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nm.3411","volume":"20","author":"F Carbone","year":"2014","unstructured":"Carbone, F. et al. Regulatory t cell proliferative potential is impaired in human autoimmune disease. Nat. Med. 20, 69\u201374. https:\/\/doi.org\/10.1038\/nm.3411 (2014).","journal-title":"Nat. Med."},{"key":"23601_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.imlet.2020.04.011","volume":"223","author":"H Hashimoto","year":"2020","unstructured":"Hashimoto, H., McCallion, O., Kempkes, R. W. M., Hester, J. & Issa, F. Distinct metabolic pathways mediate regulatory t cell differentiation and function. Immunol. Lett. 223, 53\u201361. https:\/\/doi.org\/10.1016\/j.imlet.2020.04.011 (2020).","journal-title":"Immunol. Lett."},{"key":"23601_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12868-018-0482-4","volume":"19","author":"MA Zimmerman","year":"2018","unstructured":"Zimmerman, M. A., Biggers, C. D. & Li, P. A. Rapamycin treatment increases hippocampal cell viability in an mtor-independent manner during exposure to hypoxia mimetic, cobalt chloride. BMC Neurosci. 19, 82. https:\/\/doi.org\/10.1186\/s12868-018-0482-4 (2018).","journal-title":"BMC Neurosci."},{"key":"23601_CR45","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara, M. et al. Functional delineation and differentiation dynamics of human cd4+ t cells expressing the foxp3 transcription factor. Immunity 30, 899\u2013911. https:\/\/doi.org\/10.1016\/j.immuni.2009.03.019 (2009).","journal-title":"Immunity"},{"key":"23601_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4049\/jimmunol.177.2.840","volume":"177","author":"HW Lim","year":"2006","unstructured":"Lim, H. W., Broxmeyer, H. E. & Kim, C. H. Regulation of trafficking receptor expression in human forkhead box p3+ regulatory t cells. J. Immunol. 177, 840\u2013851. https:\/\/doi.org\/10.4049\/jimmunol.177.2.840 (2006).","journal-title":"J. Immunol."},{"key":"23601_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e","volume":"7","author":"HA Edmondson","year":"1954","unstructured":"Edmondson, H. A. & Steiner, P. E. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 7, 462\u2013503. https:\/\/doi.org\/10.1002\/1097-0142(195405)7:3%3c462::aid-cncr2820070308%3e3.0.co;2-e (1954).","journal-title":"Cancer"},{"key":"23601_CR48","first-page":"4951","volume":"30","author":"R Gedaly","year":"2010","unstructured":"Gedaly, R. et al. Pi-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking ras\/raf\/mapk and pi3k\/akt\/mtor pathways. Anticancer Res. 30, 4951\u20134958 (2010).","journal-title":"Anticancer Res."},{"key":"23601_CR49","first-page":"1709","volume":"34","author":"R Galuppo","year":"2014","unstructured":"Galuppo, R. et al. Synergistic inhibition of hcc and liver cancer stem cell proliferation by targeting ras\/raf\/mapk and wnt\/beta-catenin pathways. Anticancer Res. 34, 1709\u20131713 (2014).","journal-title":"Anticancer Res."},{"key":"23601_CR50","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/tri.12989","volume":"30","author":"V Vilchez","year":"2017","unstructured":"Vilchez, V. et al. Evidence of the immunomodulatory role of dual pi3k\/mtor inhibitors in transplantation: An experimental study in mice. Transplant. Int. 30, 1061\u20131074. https:\/\/doi.org\/10.1111\/tri.12989 (2017).","journal-title":"Transplant. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23601-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:19:05Z","timestamp":1668021545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23601-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23601"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23601-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RG, DSW, CL and FM are holding patents IR-2321 and IR-2349 for NAB derivative Y3. Competing interest is not applicable for remaining authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19112"}}